Back
NBT Bancorp Vs. Crinetics Pharmaceuticals Industry Stock Comparison
Sell
34
NBTB
NBT Bancorp
Last Price:
$45.20
Seasonality Move:
-1.87%
Sell
8
CRNX
Crinetics Pharmaceuticals
Last Price:
$40.59
Seasonality Move:
-9.08%
Sell
34
NBT Bancorp (NBTB)
is a Sell
Is NBT Bancorp a Buy, Sell or Hold?
-
The current NBT Bancorp [NBTB] share price is $46.38. The Score for NBTB is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
NBTB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
8
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals [CRNX] share price is $48.50. The Score for CRNX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
NBTB Stock Price Chart
What is NBT Bancorp's stock price today?
-
The NBT Bancorp share price today is $46.38Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBTB is experiencing slight selling pressure.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $48.50Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.
NBTB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.65 | Sell |
Relative Strength Index (14 RSI): | 35.22 | Sell |
Chaikin Money Flow: | -22875 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.62 - 50.84) | Sell |
Bollinger Bands (100): | (44.5 - 49.68) | Sell |
CRNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.69 | Sell |
Relative Strength Index (14 RSI): | 34.32 | Sell |
Chaikin Money Flow: | -235099 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.1 - 56.94) | Sell |
Bollinger Bands (100): | (51.5 - 57.46) | Sell |
NBTB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.46 | Sell |
20-day SMA: | 49.1 | Sell |
50-day SMA: | 48.82 | Sell |
200-day SMA: | 42.9 | Buy |
8-day EMA: | 47.46 | Sell |
20-day EMA: | 48.39 | Sell |
50-day EMA: | 48.28 | Sell |
200-day EMA: | 44.14 | Buy |
CRNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.85 | Sell |
20-day SMA: | 53.18 | Sell |
50-day SMA: | 55.63 | Sell |
200-day SMA: | 51.03 | Sell |
8-day EMA: | 50.82 | Sell |
20-day EMA: | 52.67 | Sell |
50-day EMA: | 54.22 | Sell |
200-day EMA: | 49.96 | Sell |
NBT Bancorp Earnings Growth & NBTB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.79 per share.
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.
NBT Bancorp Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Crinetics Pharmaceuticals Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |